Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2006-03-07
2006-03-07
Barts, Samuel (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S345000, C514S646000, C514S603000, C558S414000, C558S418000, C564S431000, C564S086000, C546S297000
Reexamination Certificate
active
07008962
ABSTRACT:
This invention relates to the novel use of dianilino squarates in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).
REFERENCES:
patent: WO 96/25157 (1996-08-01), None
patent: WO 01/64208 (2001-09-01), None
Data CAPLUS on STN, AN 1999:79153. Chen et al. Chemical Abstract Online Printout, “Synthesis of asymetric aryl-substituted amides of squaric acid and asymetric isosquarylium amides”, Hecheng Huaxue, 1998, vol. 6, No. 4, pp. 383-392.
Bi Guangping
McCleland Brent
Palovich Michael R.
Werner Michelle
Widdowson Katherine L.
Barts Samuel
Kinzig Charles M.
McCarthy Mary E.
Simon Soma G.
Smithkline Beecham Corporation
LandOfFree
IL-8 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with IL-8 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IL-8 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3608503